Trial | Chief investigator (CI) or senior team member interviewed? | Patient and public involvement (PI) interviewed? | Trial manager interviewed? | Setting* | Intervention |
---|---|---|---|---|---|
1 | Y | Y | N | Community | Education and exercise |
2 | Y | Y | N | Tertiary | Device |
3 | Y | Y | Y | Secondary | Education |
4 | Y | N | N | Tertiary | Drug |
5 | Y | N | Y | Secondary | Surgical |
6 | Y | Y | N | Secondary | Exercise |
7 | Y | Y | N | Primary | Community care |
8 | Y | Y (2 PPI contributors) | Y | Tertiary | Drug |
9 | Y | Y | Y | Secondary | Device |
10 | Y | N | N | Social care | Exercise |
11 | Y | Y (2 PPI contributors) | Y | Secondary | Surgical |
12 | Y | N | N | Secondary | Device |
13 | Y | N | Y | Secondary | Drug |
14 | Y | N | N | Secondary | Surgical |
15 | Y | Y | Y | Primary | Exercise |
16 | Y | N | N | Primary | Exercise |
17 | Y | N | N | Secondary | Surgical |
18 | Y | N | Y | Primary and secondary | Exercise and community care |
19 | Y | N | N | Primary | Other |
20 | Y | N | N | Emergency | Community care |
21 | Y | N | Y | Secondary | Device |
22 | N | Y | N | Secondary | Surgical |
23 | N | Y | N | Secondary | Device |
24 | N | Y | N | Tertiary | Drug |
25 | N | Y | N | Emergency | Surgical |
26 | N | Y | N | Secondary, Tertiary | Surgical |
27 | N | Y | Y | Emergency | Drug |
28 | N | Y | N | Secondary | Device |